Literature DB >> 18228120

Jak2/Stat5 signaling in mammogenesis, breast cancer initiation and progression.

Kay-Uwe Wagner1, Hallgeir Rui.   

Abstract

During normal mammary gland development, the tyrosine kinase Jak2 and its main substrate, the signal transducer and activator of transcription-5 (Stat5), are critical for the growth and differentiation of alveolar progenitors as well as the survival of secretory mammary epithelial cells. Genetic studies in mouse models support a role for the Stat5 transcription factor as a proto-oncogene in mammary tumor initiation. On the other hand, the analysis of nuclear Stat5 in human breast malignancies suggests a role of the Jak2/Stat5 pathway in the restriction of the metastatic potential of neoplastic mammary epithelial cells. Following an overview on the function of the Jak2/Stat5 pathway during normal mammary gland development, this review discusses recently published observations on human breast cancers as well as experimental evidence from genetically engineered mice that propose a dual role of Jak2/Stat5 signaling in breast cancer initiation and progression. Future studies to further test the concept of contrasting effects of Jak2/Stat5 pathway on breast cancer initiation and metastatic progression are proposed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18228120     DOI: 10.1007/s10911-008-9062-z

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  101 in total

1.  Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation.

Authors:  Yongzhi Cui; Greg Riedlinger; Keiko Miyoshi; Wei Tang; Cuiling Li; Chu-Xia Deng; Gertraud W Robinson; Lothar Hennighausen
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

2.  Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.

Authors:  Tianhong Li; Federica Sotgia; Magalis A Vuolo; Maomi Li; Wan Cai Yang; Richard G Pestell; Joseph A Sparano; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

3.  The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development.

Authors:  Richard W E Clarkson; Marion P Boland; Ekaterini A Kritikou; Jennifer M Lee; Tom C Freeman; Paul G Tiffen; Christine J Watson
Journal:  Mol Endocrinol       Date:  2005-11-17

4.  IGF-2 is a mediator of prolactin-induced morphogenesis in the breast.

Authors:  Cathrin Brisken; Ayyakkannu Ayyannan; Cuc Nguyen; Anna Heineman; Ferenc Reinhardt; Jian Tan; S K Dey; G Paolo Dotto; Robert A Weinberg; Tian Jan
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

5.  STAT 5a expression in various lesions of the breast.

Authors:  Gary L Bratthauer; Brian L Strauss; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2005-08-19       Impact factor: 4.064

6.  Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade.

Authors:  David S Park; Hyangkyu Lee; Philippe G Frank; Babak Razani; Andrew V Nguyen; Albert F Parlow; Robert G Russell; James Hulit; Richard G Pestell; Michael P Lisanti
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

7.  Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.

Authors:  Vivian Hwa; Brian Little; Pelin Adiyaman; Eric M Kofoed; Katherine L Pratt; Gonul Ocal; Merih Berberoglu; Ron G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  2005-04-12       Impact factor: 5.958

8.  Transactivating agonists of the EGF receptor require Tyr 845 phosphorylation for induction of DNA synthesis.

Authors:  Julie L Boerner; Jacqueline S Biscardi; Corinne M Silva; Sarah J Parsons
Journal:  Mol Carcinog       Date:  2005-12       Impact factor: 4.784

9.  Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer.

Authors:  H Yamashita; M Nishio; Y Ando; Z Zhang; M Hamaguchi; K Mita; S Kobayashi; Y Fujii; H Iwase
Journal:  Endocr Relat Cancer       Date:  2006-09       Impact factor: 5.678

10.  Stat5a is mandatory for adult mammary gland development and lactogenesis.

Authors:  X Liu; G W Robinson; K U Wagner; L Garrett; A Wynshaw-Boris; L Hennighausen
Journal:  Genes Dev       Date:  1997-01-15       Impact factor: 11.361

View more
  71 in total

1.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

2.  Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland.

Authors:  Sonja E Volker; Shannon E Hedrick; Yvonne B Feeney; Charles V Clevenger
Journal:  Cancer Res       Date:  2018-06-29       Impact factor: 12.701

Review 3.  Minireview: prolactin regulation of adult stem cells.

Authors:  Lucila Sackmann-Sala; Jacques-Emmanuel Guidotti; Vincent Goffin
Journal:  Mol Endocrinol       Date:  2015-03-20

4.  Gene expression during successful implantation in a natural cycle.

Authors:  Inge Van Vaerenbergh; Ramsey McIntire; Leentje Van Lommel; Paul Devroey; Linda Giudice; Claire Bourgain
Journal:  Fertil Steril       Date:  2009-10-31       Impact factor: 7.329

5.  Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells.

Authors:  Alison E Obr; Sandra L Grimm; Kathleen A Bishop; J Wesley Pike; John P Lydon; Dean P Edwards
Journal:  Mol Endocrinol       Date:  2013-09-06

6.  Identification of condition-specific regulatory modules through multi-level motif and mRNA expression analysis.

Authors:  Li Chen; Jianhua Xuan; Yue Wang; Eric P Hoffman; Rebecca B Riggins; Robert Clarke
Journal:  Int J Comput Biol Drug Des       Date:  2009

7.  Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.

Authors:  K Sakamoto; A A Triplett; L A Schuler; K-U Wagner
Journal:  Oncogene       Date:  2010-07-19       Impact factor: 9.867

8.  Distinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5.

Authors:  Tali Eilon; Itamar Barash
Journal:  BMC Genomics       Date:  2009-05-18       Impact factor: 3.969

9.  ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway.

Authors:  Tatiana Vignudelli; Tommaso Selmi; Andrea Martello; Sandra Parenti; Alexis Grande; Claudia Gemelli; Tommaso Zanocco-Marani; Sergio Ferrari
Journal:  Mol Biol Cell       Date:  2010-08-11       Impact factor: 4.138

10.  TCDD exposure disrupts mammary epithelial cell differentiation and function.

Authors:  Loretta L Collins; Betina J Lew; B Paige Lawrence
Journal:  Reprod Toxicol       Date:  2009-03-13       Impact factor: 3.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.